Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Clumeck

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupC Katlama, D Ingrand, C Loveday, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1998
Nutritional status and antiprotease therapyM L Delforge, S Farine, C Liesnard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1994
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)R Snoeck, G Andrei, M Gérard, et al.
The New England Journal of Medicine|February 23, 1984
Acquired immunodeficiency syndrome in African patientsN Clumeck, J Sonnet, H Taelman, et al.
AIDS (London, England)|February 1, 1993
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative GroupD A Cooper, P O Pehrson, C Pedersen, et al.
AIDS (London, England)|August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAN Clumeck, F Goebel, W Rozenbaum, et al.
Lancet (London, England)|July 14, 1984
Acquired immunodeficiency syndrome in RwandaP Van de Perre, D Rouvroy, P Lepage, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
BMJ (Clinical Research Ed.)|April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupJ D Lundgren, C Pedersen, N Clumeck, et al.
The Journal of Infectious Diseases|November 1, 1993
Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDSR Snoeck, M Gérard, C Sadzot-Delvaux, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupC Katlama, D Ingrand, C Loveday, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1998
Nutritional status and antiprotease therapyM L Delforge, S Farine, C Liesnard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1994
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)R Snoeck, G Andrei, M Gérard, et al.
The New England Journal of Medicine|February 23, 1984
Acquired immunodeficiency syndrome in African patientsN Clumeck, J Sonnet, H Taelman, et al.
AIDS (London, England)|February 1, 1993
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative GroupD A Cooper, P O Pehrson, C Pedersen, et al.
AIDS (London, England)|August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAN Clumeck, F Goebel, W Rozenbaum, et al.
Lancet (London, England)|July 14, 1984
Acquired immunodeficiency syndrome in RwandaP Van de Perre, D Rouvroy, P Lepage, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
BMJ (Clinical Research Ed.)|April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupJ D Lundgren, C Pedersen, N Clumeck, et al.
The Journal of Infectious Diseases|November 1, 1993
Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDSR Snoeck, M Gérard, C Sadzot-Delvaux, et al.
Pageof 20